use
extracorpor
membran
oxygen
ecmo
support
increas
recent
year
especi
follow
pandem
influenza
viru
pneumon
although
result
previou
random
trial
ecmo
use
respiratori
support
inconclus
new
technolog
associ
applic
ultraprotect
mechan
ventil
improv
surviv
qualiti
life
ecmo
use
patient
sever
respiratori
failur
high
cost
train
support
requir
ecmo
use
may
neg
econom
impact
especi
develop
countri
howev
high
cost
initi
instal
system
compens
low
cost
mainten
good
outcom
obtain
ecmo
support
use
adequ
staff
train
make
therapi
costeffect
develop
countri
potenti
costeffect
develop
countri
consid
ensur
avail
appropri
staff
health
center
rel
small
occup
rate
may
increas
cost
extracorpor
support
ecmoequip
transport
special
center
made
avail
accept
cost
high
surviv
rate
improv
qualiti
life
consid
import
transport
ecmo
object
studi
character
transport
perform
team
state
paulo
sinc
data
consid
nonparametr
small
sampl
size
report
median
percentil
quantit
number
occurr
percentag
qualit
comparison
group
present
tabl
perform
use
mannwhitney
test
quantit
data
fisher
exact
test
qualit
data
confid
interv
survivor
ratio
calcul
accord
method
describ
associ
public
health
observatori
use
r
softwar
calcul
graph
creation
ecmo
program
initi
transport
ecmo
patient
began
year
flowchart
request
extracorpor
support
outsid
referr
hospit
shown
figur
first
seven
patient
seri
describ
anoth
public
six
year
program
patient
state
paulo
rescu
transport
ecmo
support
team
seventeen
patient
receiv
exclus
respiratori
support
venoven
vv
configur
one
patient
receiv
respiratori
cardiovascular
support
venoarteri
va
configur
profil
patient
shown
tabl
characterist
patient
shortli
initi
support
shown
tabl
respiratori
ecmo
surviv
predict
score
resp
score
tidal
volum
preecmo
mechan
ventil
differ
significantli
survivor
nonsurvivor
data
rescu
mission
complic
transport
shown
tabl
referr
hospit
hospit
two
patient
hospit
totalcor
two
patient
hospit
da
paulo
patient
data
extracorpor
support
shown
tabl
respiratori
support
provid
use
femoraljugular
configur
venoarteri
support
one
case
provid
use
femoralfemor
configur
venou
cannula
fr
arteri
cannula
fr
apart
venoarteri
cannul
anticoagul
start
upon
patient
arriv
referr
hospit
five
patient
use
anticoagul
time
pulmonari
hemorrhag
four
case
presenc
cerebr
vascul
hemorrhag
area
one
case
none
evalu
patient
chang
itinerari
chang
support
configur
relat
initi
cannul
final
result
shown
tabl
minimum
maximum
durat
support
day
respect
patient
ci
surviv
hospit
admiss
figur
survivor
one
patient
need
dialysi
hospit
admiss
none
requir
home
oxygen
therapi
individu
patient
data
present
tabl
case
seri
sever
patient
transport
special
center
ecmo
support
paulo
rate
complic
low
hospit
surviv
patient
discharg
hospit
one
need
renal
replac
therapi
none
requir
home
oxygen
therapi
fewer
patient
admit
intens
care
unit
icu
suffer
sever
respiratori
failur
fewer
refractori
protect
mechan
ventil
salvag
therapi
hypoxemia
sever
hypercapnia
sometim
requir
ecmo
support
low
rate
sever
patient
limit
abil
maintain
team
perform
ecmo
support
icu
therefor
develop
countri
transport
instal
ecmo
support
use
reduc
risk
transport
special
center
patient
surviv
rate
ci
seri
hospit
surviv
ci
agreement
data
report
literatur
result
attribut
two
main
caus
first
use
rigor
inclus
exclus
criteria
result
restrict
use
ecmo
highli
select
patient
ecmo
support
seem
surviv
benefit
improv
qualiti
life
patient
comorbid
acut
dysfunct
addit
applic
rescu
therapi
use
prone
posit
ecmo
essenti
whenev
possibl
therapi
inexpens
strong
evid
use
improv
patient
surviv
second
use
ecmo
support
optim
provid
adequ
train
experi
multidisciplinari
team
involv
profession
possess
comprehens
knowledg
emerg
care
possibl
complic
ecmo
support
studi
comparison
survivor
nonsurvivor
consid
preliminari
small
sampl
size
howev
certain
factor
consid
initi
tidal
volum
patient
die
lower
surviv
suggest
greater
sever
lung
injuri
poorer
lung
complianc
former
simplifi
acut
physiolog
score
sap
differ
two
group
resp
score
use
decisionmak
higher
survivor
although
resp
score
develop
mean
predict
patient
surviv
ecmo
support
score
develop
predict
patient
surviv
better
address
organ
function
may
therefor
accur
surviv
venoarteri
ecmo
score
save
score
describ
effect
use
score
analyz
use
one
case
anoth
relev
factor
sampl
nonsurvivor
partial
pressur
decreas
carbon
dioxid
pre
postecmo
critic
characterist
known
relat
higher
patient
mortal
ecmo
factor
may
contribut
death
two
patient
progress
brain
death
icu
outcom
alert
us
import
care
initi
extracorpor
ventil
especi
hypercapn
patient
gasblood
flow
ensur
smaller
initi
decreas
seriou
problem
aros
transport
address
follow
energi
failur
avoid
use
hand
pump
one
patient
turn
warn
light
anoth
patient
ambul
power
invert
dedic
oper
pump
decreas
oxygen
satur
observ
dessatur
occur
sever
lung
injuri
associ
cardiac
output
sever
hypoxemia
may
occur
acut
phase
respiratori
support
sometim
need
toler
team
although
complic
may
directli
affect
surviv
cognit
outcom
indic
sever
patient
condit
although
sampl
describ
studi
provid
new
data
repres
first
case
seri
patient
transport
ecmo
brazil
howev
result
studi
view
caution
sever
reason
first
sampl
size
small
possibl
perform
multivari
analysi
second
result
analys
preliminari
use
chang
procedur
bedsid
third
gener
result
report
center
made
caution
number
ecmo
support
case
per
year
low
fourth
indic
restrict
small
subset
patient
certain
condit
ecmo
effect
costeffect
therapi
result
case
seri
demonstr
approach
effect
restrict
indic
follow
adequ
intens
care
provid
avoid
complic
hospit
staff
involv
patient
care
continu
train
enabl
treat
lifethreaten
complic
may
occur
ecmo
support
opinion
achiev
center
maintain
costeffect
therapi
transport
sever
ill
patient
extracorpor
respiratori
support
brazilian
state
feasibl
result
sever
complic
despit
small
sampl
size
patient
surviv
hospit
admiss
similar
report
literatur
